The Francis Crick Institute - Cancer Evolution and Genome Instability Laboratory, Roche Tissue Diagnostics, The Francis Crick Institute - Cancer Evolution and Genome Instability Laboratory, Roche Tissue Diagnostics, The Francis Crick Institute - Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute - Cancer Evolution and Genome Instability Laboratory, Roche Sequencing Solutions, Institut de Cancérologie de Lorraine - Biopathology Service, The Francis Crick Institute - Cancer Evolution and Genome Instability Laboratory, Roche Tissue Diagnostics, Royal Marsden Hospital, Royal Marsden Hospital, The Francis Crick Institute - Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, Roche Tissue Diagnostics, Roche Tissue Diagnostics, Roche Tissue Diagnostics, Roche Sequencing Solutions, The Francis Crick Institute - Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute - Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute - Cancer Evolution and Genome Instability Laboratory, Aarhus University Hospital - Department of Molecular Medicine, Aarhus University Hospital - Department of Molecular Medicine, Aarhus University Hospital - Department of Molecular Medicine, Royal Marsden NHS Foundation Trust, University College London - Cancer Research UK Lung Cancer Centre of Excellence, Royal Marsden NHS Foundation Trust - Renal and Skin Units, The Francis Crick Institute - Cancer Evolution and Genome Instability Laboratory, Roche Tissue Diagnostics and The Francis Crick Institute - Cancer Evolution and Genome Instability Laboratory

Institut de Cancérologie de Lorraine - Biopathology Service, Institut de Cancérologie de Lorraine, Centre Georges-François Leclerc, Institut de Cancérologie de Lorraine - Biopathology Service and Institut de Cancérologie de Lorraine - Biopathology Service